Fierce Pharma

JULY 21, 2023

In this episode of 'The Top Line' we replay an important show from April 28, 2023 regarding Narcan. | This week on "The Top Line," we revisit an episode on Narcan the nasal spray. It is the first naloxone product to be approved for use without a prescription.

Specialization 211

Specialization Prescription 211

Progressive Medical

SEPTEMBER 22, 2023

Vial2Bag Advanced® 20mm Admixture Device: Waste Reduction in IV Distribution Large-scale drug waste is an ongoing problem in health care […] The post Vial2Bag Advanced® 20mm Admixture Device Special Report #2 appeared first on Progressive Medical, Inc.

Specialization 52

Specialization Distribution Medical 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. Speciality pharmacies provide comprehensive medications for individuals with serious medical conditions requiring complex treatments, including cancer, cystic fibrosis, haemophilia, hepatitis, HIV, and others.

Specialization 45

Specialization Leads Pharma Side effects 45

Progressive Medical

APRIL 25, 2023

Vial2Bag Advanced® 20mm Admixture Device: Cost Reduction and Operational Efficiency in IV Medication Distribution In recent years, hospital administrators involved […] The post Vial2Bag Advanced® 20mm Admixture Device Special Report appeared first on Progressive Medical, Inc.

Specialization 52

Specialization Distribution Medical 52

MedCity News

OCTOBER 25, 2022

Hospital for Special Surgery spun out a new startup called RightMove Powered by HSS. The company will offer patients virtual triage services and nonsurgical physical therapy. Along with its launch, RightMove announced a $21 million Series A funding round led by Flare Capital and HSS.

Specialization 92

Specialization Patients 92

Clarivate

JUNE 6, 2024

The post [Special Report] Trademark filing and litigation trends 2024: Insights and opportunities appeared first on Clarivate. This is our Think forward promise — we will work to connect you to intelligence you can trust to ensure an IP-empowered tomorrow.

Specialization 64

Specialization Retail Engineering Marketing 64

Copyright Clearance Center

MAY 22, 2023

The post 2023 Prix Voltaire Special Award To Volodymyr Vakulenko appeared first on Copyright Clearance Center.

Specialization 52

Specialization 52

Fierce Pharma

SEPTEMBER 3, 2024

Semnur Pharmaceuticals, which is working on a non-opioid prospect for sciatica, has agreed to merge with special purpose acquisition company Denali Capital Acquisition Corp. Semnur Pharmaceuticals is following in its parent company Scilex's footsteps with a special purpose acquisition company (SPAC) merger.

Prospecting 263

Prospecting Pharmaceutical Specialization 263

Evolve Your Success

MAY 15, 2024

A Mother’s Day special! Here’s How » Join the Medical Sales Podcast Community today: evolveyoursuccess.com The post Leading Sales Teams To Global Success: A Mother’s Day Special With Sydney Selby appeared first on Evolve Your Success. Subscribe, rate, review, and share!

Specialization 52

Specialization Sales Leads Medical sales 52

MedCity News

NOVEMBER 13, 2023

It’s easy to oversimplify and say, “These big tech companies are now doing healthcare and they’re going to solve everything.” But the reality is that often, the solutions are not going to come from big tech.

Specialization 116

Specialization Healthcare Healthcare 116

Pharmacy Times

APRIL 9, 2024

Challenges in treating insomnia in special groups and resistant cases, and ways for pharmacists to improve outcomes.

Specialization 40

Specialization Management 40

Pharmacy Times

APRIL 10, 2024

The results demonstrated similar overall survival between patients with chronic lymphocytic leukemia who discontinued specialized follow-ups versus those who continued.

Specialization 42

Specialization Patients 42

Legacy MEDSearch

OCTOBER 27, 2023

an innovator in the field of orthopedic surgical robots, today announced that its TMINI Miniature Robotic System has received Special 510(k) clearance from the U.S. THINK Surgical, Inc., Food and Drug Administration (FDA) for use with implants from three additional implant manufacturers. Are you hiring?

Specialization 52

Specialization FDA Food and Drug Administration Recruitment 52

Fierce Pharma

SEPTEMBER 10, 2024

In this week's episode of "The Top Line," we will dive into the annual Fierce 50 special | In this week's episode of "The Top Line," we will dive into the annual Fierce 50 special report.

Specialization 130

Specialization 130

Pharmacy Times

SEPTEMBER 8, 2022

Pharmacists handle public vaccination efforts and need to assess where patients are on the hesitancy spectrum to provide reliable information.

Specialization 52

Specialization Patients 52

Pharmacy Times

AUGUST 18, 2023

Opportunities for an additional specialization in molecular pathology may be helpful to train professionals in the real-time interpretation of gene therapy test results.

Specialization 49

Specialization Medicine Training 49

Fierce Pharma

AUGUST 16, 2024

Even as supplies of Novo Nordisk’s immensely popular GLP-1 drugs Ozempic and Wegovy start to stabilize, the Danish drugmaker continues to announce manufacturing and capacity upgrades at a rapid cli | Novo Nordisk Pharmatech, a unit that specializes in producing drug ingredients, is spending 1.5

Specialization 304

Specialization Manufacturing 304

Fierce Pharma

DECEMBER 1, 2023

In this episode of "The Top Line," we're highlighting the remarkable women featured in our annual Fiercest Women in Life Sciences special report. | In this episode of "The Top Line," we're highlighting the remarkable women featured in our annual Fiercest Women in Life Sciences special report.

Specialization 248

Specialization Pharma 248

Pharmacy Times

FEBRUARY 2, 2024

Older adults, patients with weakened immune systems, individuals living in long-term facilities, and those with underlying cardiopulmonary disease are at a higher risk of developing severe RSV infection outcomes.

Specialization 52

Specialization Patients 52

MedCity News

JUNE 16, 2023

When using ChatGPT, it’s crucial to consider the potential risks of the “hallucination effect.” ” This phenomenon refers to the model’s tendency to express responses with unwarranted confidence, even when the information is uncertain or inaccurate.

Specialization 94

Specialization 94

Pharmacy Times

JUNE 22, 2022

Even if the financial resources were available, there aren’t enough human resources in pharmacy to provide high-touch engagement to the millions of patients who suffer from common chronic diseases.

Specialization 72

Specialization Patients 72

Fierce Pharma

AUGUST 18, 2023

Novartis’ Sandoz spinoff is right around the corner, and, to celebrate the occasion, the Swiss pharma is plotting a special stock distribution scheme. Novartis’ Sandoz spinoff is right around the corner, and to celebrate the occasion, the Swiss pharma is plotting a special stock distribution scheme.

Distribution 227

Distribution Specialization Pharma 227

Fierce Pharma

APRIL 25, 2024

Fierce Pharma publishes a yearly special report highlighting the top 20 pharmas based on their revenue. This week on "The Top Line," Fierce Pharma Senior Editor Eric Sagonowsky and Staff Writer Kevin Dunleavy are diving into our annual top pharma companies by revenue special report.

Pharma 130

Pharma Specialization 130

Fierce Pharma

MARCH 15, 2024

Antibody-drug conjugates are a promising biopharma modality but specialized expertise is instrumental for successfully bringing drugs to the clinic. Over the last several decades, mounting interest has positioned bioconjugate therapeutics as one of the most promising biopharmaceutical modalities.

Biopharma 241

Biopharma Specialization 241

Fierce Pharma

JANUARY 18, 2024

At Fierce Pharma, the arrival of a new year is synonymous with the release of our annual special report on drug approvals. | At Fierce Pharma, the arrival of a new year is synonymous with the release of our annual special report on drug approvals.

Specialization 130

Specialization Pharma 130

Fierce Pharma

DECEMBER 4, 2023

Those are: Fujifilm Cellular Dynamics, which specializes in development and manufacturing of human induced pluripotent stem cells (iPSC), and the organization’s CDMO for biologics and advanced therapies, Fujifilm Diosynth Biotechnologies. Fujifilm is dividing $200 million between a pair of subsidiaries.

Specialization 297

Specialization Manufacturing 297

Fierce Pharma

AUGUST 19, 2024

Eight months after Visiox Pharmaceuticals was all set to go public via a special purpose acquisition company (SPAC) deal, the company has been

Specialization 130

Specialization Pharmaceutical 130

Pharmaceutical Technology

MARCH 3, 2023

The post How a specialized commercial program management team can improve your customer experience and accelerate commercialization appeared first on Pharmaceutical Technology. For more information about how Baxter BioPharma Solutions manufacturing expertise can support your project, download the content below. 

Specialization 52

Specialization Management Manufacturing Biopharma 52

PharmExec

JANUARY 4, 2024

JAMA study investigates whether physical or behavioral healthcare needs are associated with the risk of underinsurance across household income levels.

Specialization 52

Specialization Healthcare Healthcare 52

MedCity News

NOVEMBER 7, 2024

Avid specializes in manufacturing biologic products for companies at all stages of development. CDMO Avid Bioservices is being acquired by the private equity firms GHO Capital Partners and Ampersand Capital Partners. The post Private Equity Is Picking Up Biologics CDMO Avid Bioservices in $1.1B Acquisition appeared first on MedCity News.

Specialization 113

Specialization Manufacturing Biopharma Pharma 113

Fierce Pharma

JULY 10, 2024

In this week's episode of "The Top Line," Fierce Pharma’s Eric Sagonowsky and Fraiser Kansteiner discuss Fierce’s annual special report, “Big Pharma's 10 highest-paid CEOs.” Pharmaceutical CEOs often earn pay packages worth tens of millions of dollars for leading the top drugmaking companies in the industry. |

Specialization 144

Specialization Pharma Leads Pharmaceutical 144

Fierce Pharma

OCTOBER 2, 2023

ICER submitted a special report to CMS weighing evidence on Bristol Myers Squibb and Pfizer’s Eliquis and Bayer and Johnson & Johnson’s Xarelto to treat nonvalvular atrial fibrillation (NVAF), the condition where both drugs garner most of their prescriptions. As a new age of price negotiations dawns in the U.S.,

Prescription 261

Prescription Specialization 261

MedCity News

JULY 25, 2024

This would bring together specialized staff and resources from multiple review divisions to leverage their expertise about different bodily systems, trial designs, pharmacology, and other specialized fields. To bring cross-agency clinical leaders together, the FDA should establish a Center of Excellence for Rare Diseases.

FDA 107

FDA Pharmacology Patients Specialization 107

PharmExec

JANUARY 4, 2024

JAMA study investigates whether physical or behavioral healthcare needs are associated with the risk of underinsurance across household income levels.

Specialization 40

Specialization Healthcare Healthcare 40